SWINE 
CIRBLOC®
Monovalent PCV2 vaccine based on consensus PCV2d antigen platform protecting against all relevant PCV2 genotypes.
Available in:
- 100 ml
Product information
CIRBLOC® is a monovalent vaccine developed to provide reliable, targeted protection against Porcine Circovirus type 2 (PCV2).
Based on a consensus PCV2d antigen formulation, CIRBLOC® reflects the evolution of PCV2 epidemiology and is designed to protect against all relevant circulating PCV2 genotypes.
Why choose product
Unique consensus PCV2d
antigen formulation
Built on CIRBLOC® M Hyo’s
foundation, in a
monovalentformat
Flexibility to choose
your strategy with
uncompromised efficacy
Related Services
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.
